The abnormal expression of GLT‐1 is closely related to various neurological disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), epilepsy, and autism.26 This evidence concerns the gene SLC1A2 and amyotrophic lateral sclerosis.